Colorado 2025 Regular Session

Colorado Senate Bill SB072

Introduced
1/22/25  
Refer
1/22/25  
Report Pass
2/4/25  
Refer
2/4/25  
Report Pass
4/25/25  
Refer
4/25/25  
Engrossed
4/28/25  
Refer
4/28/25  
Report Pass
4/29/25  
Refer
4/29/25  
Report Pass
5/6/25  
Refer
5/6/25  
Enrolled
5/7/25  
Engrossed
5/15/25  
Engrossed
5/15/25  
Enrolled
5/15/25  

Caption

Regulation of Kratom

Impact

If enacted, SB072 would introduce new regulations into Colorado law regarding the handling and marketing of kratom products. Businesses that produce or sell kratom would need to comply with labeling requirements and ensure their products do not appeal to children or contain harmful additives. The bill would categorize certain sales practices as deceptive trade practices, thus enhancing enforcement against non-compliant retailers and possibly protecting consumers from unsafe products. This regulatory framework would be a significant step in addressing public health and safety concerns surrounding kratom sales and consumption.

Summary

Senate Bill 072, also known as the Daniel Bregger Act, seeks to regulate the sale and distribution of kratom, a plant-based substance derived from the Mitragyna speciosa tree. The bill establishes a series of legal definitions associated with kratom products, including what constitutes 'adulterated' and 'synthetic' kratom. It explicitly prohibits the sale of certain kratom products that could pose health risks, such as those containing high levels of specific alkaloids, and places strict age restrictions on sales to individuals under the age of 21. The legislation aims to ensure consumer safety and protect vulnerable populations from potentially harmful substances.

Sentiment

The sentiment around SB072 appears to be largely supportive among those advocating for consumer safety and public health. Proponents of the bill argue that it is necessary to mitigate the risks associated with kratom usage, especially among younger individuals. However, there is some concern among opponents about overregulation potentially harming legitimate businesses and access to natural remedies. The debate reflects broader themes of balancing public safety with personal freedom and market accessibility, contributing to a mixed but generally cautious sentiment surrounding the bill.

Contention

Notable points of contention include the categorization of kratom and the inclusion of specific restrictions on its sales, such as the prohibition of sales to minors and the requirement to avoid specific marketing practices. Opponents argue that such measures may lead to an unnecessary crackdown on kratom availability, while supporters underscore the need for stringent regulations to prevent misuse and abuse. As kratom's legal status continues to be a contentious issue at both state and federal levels, the act represents a critical intersection of public health policy, regulation, and individual rights.

Companion Bills

No companion bills found.

Similar Bills

MO SB927

Regulates the sale of kratom in the state

MS HB1076

Kratom Consumer Protection Act; create.

WY SF0056

AN ACT relating to food and drugs; regulating the sale, testing and use of kratom products as specified; authorizing the department of health and local law enforcement to enforce compliance with kratom product regulation as specified; providing definitions; providing criminal penalties; providing appropriations; authorizing full-time positions; and providing for effective dates.

LA SB154

Criminalizes the possession or distribution of kratom. (8/1/25)

OH HB587

Regards sales of kratom products

OH SB299

Regards sales of kratom products

TN SB2417

AN ACT to amend Tennessee Code Annotated, Title 33; Title 39, Chapter 17, Part 4; Title 43 and Title 57, relative to Kratom.

TN HB2594

AN ACT to amend Tennessee Code Annotated, Title 33; Title 39, Chapter 17, Part 4; Title 43 and Title 57, relative to Kratom.